Internal Medicine
M-A | Corticosteroids in community-acquired bacterial pneumonia
26 Apr, 2023 | 14:29h | UTCCorticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis – Journal of General Internal Medicine (if the link is paywalled, try this one)
Related:
RCT | Hydrocortisone reduces mortality in severe community-acquired pneumonia
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
ASCO Guideline Update | Management of anxiety and depression in adult survivors of cancer
26 Apr, 2023 | 14:27h | UTCCommentary: ASCO Updates Guideline for Management of Anxiety and Depression in Adult Cancer Survivors – ASCO Daily News
Related: Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline – ESMO Open
Commentary on Twitter
Just issued: Guideline update on the management of anxiety and depression in adult #CancerSurvivors. Read more ➡️ https://t.co/gxv0I86jHX #survonc #supponc #psyonc pic.twitter.com/hwnNgTuqSo
— ASCO (@ASCO) April 20, 2023
ESMO Guideline | Anxiety and depression in adult cancer patients
26 Apr, 2023 | 14:26h | UTCAnxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline – ESMO Open
M-A | Utility of differential time to positivity in diagnosing central line associated bloodstream infections
26 Apr, 2023 | 14:24h | UTC
Commentary on Twitter
https://twitter.com/CIDJournal/status/1648807186443673600
Opinion | Precision palliative care as a pragmatic solution for a care delivery problem
26 Apr, 2023 | 14:19h | UTC
Commentary from the author on Twitter (thread – click for more)
In the @JCO_ASCO‼️‼️, @ravi_b_parikh & I make the case for 🎯"Precision Palliative Care" 🎯as a pragmatic solution for a care delivery problem
A 🧵
Article https://t.co/1mYcaVIov4 pic.twitter.com/5Kj87rcuZK— Ramy Sedhom, MD, FASCO (@ramsedhom) April 22, 2023
Cohort Study | Associations of change in body size with all-cause and cause-specific mortality among healthy older adults
26 Apr, 2023 | 14:12h | UTCCommentary: Significant association found between all-cause mortality and weight loss in the elderly – MedicalXpress
Cohort Study | Beverage consumption and mortality among adults with type 2 diabetes
26 Apr, 2023 | 14:09h | UTCEditorial: Beverages and health outcomes in adults with type 2 diabetes – The BMJ
Commentary: Healthy Beverage Choices May Lower Mortality Risk in Adults with Diabetes – HCP Live
Review | Sepsis-associated delirium
26 Apr, 2023 | 14:10h | UTCSepsis-Associated Delirium: A Narrative Review – Journal of Clinical Medicine
M-A | Prevalence of atypical pathogens in patients with severe pneumonia
26 Apr, 2023 | 14:02h | UTC
AGA Practical Guidance | Diagnosis and management of extraesophageal gastroesophageal reflux disease
25 Apr, 2023 | 14:50h | UTCCommentary: Guidance offered on management of extraesophageal GERD – ACP Gastroenterology
Commentary on Twitter (thread – click for more)
https://twitter.com/joanwchen/status/1648804839600668675
ASCO Guideline Update | Venous thromboembolism prophylaxis and treatment in patients with cancer
25 Apr, 2023 | 14:49h | UTC
Cohort Study | Impact of work schedules of senior resident physicians on patient and resident physician safety
25 Apr, 2023 | 14:43h | UTCNews Release: National Study of Resident Physicians Suggests Need for Federal Work Hour Guideline Changes – Brigham and Women’s Hospital
Commentaries:
Resident Doctors’ Long Work Shifts Could Bring Peril to Patients – HealthDay
SR | Cranberries can prevent recurrent urinary tract infections in selected patients
25 Apr, 2023 | 14:41h | UTCCranberries for preventing urinary tract infections – Cochrane Library
Summary: Cranberries for preventing urinary tract infections – Cochrane Library
Commentaries:
Cranberry juice can prevent recurrent UTIs, but only for some people – The Conversation
Review confirms that cranberry products help prevent urinary tract infections – News Medical
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
25 Apr, 2023 | 14:42h | UTCSummary: 2023 GOLD Guidelines for Chronic Obstructive Pulmonary Disease – NEJM Journal Watch (free for a limited period)
Original Guidance: 2023 GOLD REPORT: global strategy for prevention, diagnosis and management of COPD: 2023 Report – Global Initiative for Chronic Obstructive Lung Disease
Cohort Study | Osmotic demyelination syndrome in patients hospitalized with hyponatremia
25 Apr, 2023 | 14:26h | UTCOsmotic Demyelination Syndrome in Patients Hospitalized with Hyponatremia – NEJM Evidence
Brief Review | Diagnosis and management of adrenal insufficiency
25 Apr, 2023 | 14:18h | UTCDiagnosis and management of adrenal insufficiency – Clinical Medicine Journal
Brief Review | Diagnosis and management of neuroendocrine tumors
25 Apr, 2023 | 14:16h | UTCDiagnosis and management of neuroendocrine tumours – Clinical Medicine Journal
Brief Review | Management of pituitary incidentalomas
25 Apr, 2023 | 14:14h | UTCManagement of pituitary incidentalomas – Clinical Medicine Journal
Brief Review | Investigation and assessment of adrenal incidentalomas
25 Apr, 2023 | 14:13h | UTCInvestigation and assessment of adrenal incidentalomas – Clinical Medicine Journal
USPSTF Statement | There is insufficient evidence to guide skin cancer screening recommendations
24 Apr, 2023 | 14:07h | UTCScreening for Skin Cancer: US Preventive Services Task Force Recommendation Statement – JAMA
Evidence Report: Skin Cancer Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Editorials:
Patient Page: Screening and Prevention of Skin Cancer – JAMA
Author Interview: USPSTF Recommendation: Screening for Skin Cancer – JAMA
Commentary on Twitter
2023 Recommendation Statement from the USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for #skincancer in adolescents and adults (I statement). https://t.co/WB6VN2r1Nv
— JAMA (@JAMA_current) April 18, 2023
WHO releases first-ever Standard on universal access to rapid TB diagnostics
24 Apr, 2023 | 14:04h | UTCNews Release: WHO releases first-ever Standard on universal access to rapid TB diagnostics – World Health Organization
WHO Standard: Universal access to rapid tuberculosis diagnostics – World Health Organization
RCT | Oral fluvoxamine plus inhaled budesonide reduced hospitalizations in high-risk patients with early-onset COVID-19
24 Apr, 2023 | 13:51h | UTC
Commentary on Twitter
Treatment w/ oral fluvoxamine + inhaled budesonide among high-risk outpatients w/ early #COVID19 reduced incidence of severe disease requiring advanced care. The combined effect seems to offer benefits over individual use of each drug: https://t.co/wM2da5a5MD pic.twitter.com/Sl1qFzTOjD
— Annals of Int Med (@AnnalsofIM) April 19, 2023
RCT | Bariatric–metabolic surgery is more effective than lifestyle intervention plus best medical care in non-alcoholic steatohepatitis
24 Apr, 2023 | 14:03h | UTCNews Release: Surgery most effective treatment of metabolic liver disease – King’s College London
Commentary on Twitter
New @TheLancet – Verrastro et al – Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trialhttps://t.co/pCWahvbReQ#NASH #NAFLD #fattyliver #livertwitter pic.twitter.com/xNMsAskJF9
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) April 21, 2023
RCT | Higher dose corticosteroids increase mortality in hypoxic COVID-19 patients on simple oxygen
24 Apr, 2023 | 13:55h | UTCEditorial: Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia? – The Lancet
Commentary: Higher-dose corticosteroids tied to 60% more deaths in low-oxygen COVID patients – CIDRAP
Commentary on Twitter (thread – click for more)
Low-dose corticosteroids have been shown to reduce mortality for patients with COVID-19 requiring oxygen or ventilatory support.
A new study evaluated the use of a higher dose of corticosteroids in this patient group. https://t.co/uJGSYSBQAO
— The Lancet (@TheLancet) April 13, 2023
Evidence Analysis | Blood pressure targets – how low can you get?
24 Apr, 2023 | 13:47h | UTCBlood pressure targets – how low can you get? – Evidently Cochrane
Original Article: SR | Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Commentary on Twitter
Blood pressure targets – how low can you get? https://t.co/ERLm6Mihl8 In this @CochraneUK blog, GP @rtwalton123 looks at the latest guidance & @CochraneLibrary evidence on what #BloodPressure targets to aim for, balancing the benefits of treatment against risk of side effects. pic.twitter.com/8EQH0JLzzc
— The Cochrane Library (@CochraneLibrary) April 19, 2023


